39 related articles for article (PubMed ID: 38751485)
1. Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population.
Zhou Z; Kinslow CJ; Hibshoosh H; Guo H; Cheng SK; He C; Gentry MS; Sun RC
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30769905
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtypes predict the prognosis of male breast cancer: a retrospective cohort study.
Wang M; Liu D; Zhang Z; Dai X; Chen G; Zhu L
Transl Breast Cancer Res; 2023; 4():4. PubMed ID: 38751485
[TBL] [Abstract][Full Text] [Related]
3. Survival Disparities in Male Patients With Breast Cancer.
Restrepo DJ; Boczar D; Huayllani MT; Sisti A; McLaughlin SA; Spaulding A; Parker AS; Carter RE; Leppin AL; Forte AJ
Anticancer Res; 2019 Oct; 39(10):5669-5674. PubMed ID: 31570465
[TBL] [Abstract][Full Text] [Related]
4. Male breast cancer: a disease distinct from female breast cancer.
Gucalp A; Traina TA; Eisner JR; Parker JS; Selitsky SR; Park BH; Elias AD; Baskin-Bey ES; Cardoso F
Breast Cancer Res Treat; 2019 Jan; 173(1):37-48. PubMed ID: 30267249
[TBL] [Abstract][Full Text] [Related]
5. Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis.
Liu N; Johnson KJ; Ma CX
Clin Breast Cancer; 2018 Oct; 18(5):e997-e1002. PubMed ID: 30007834
[TBL] [Abstract][Full Text] [Related]
6. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
Amin MB; Greene FL; Edge SB; Compton CC; Gershenwald JE; Brookland RK; Meyer L; Gress DM; Byrd DR; Winchester DP
CA Cancer J Clin; 2017 Mar; 67(2):93-99. PubMed ID: 28094848
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor and antiandrogen therapy in male breast cancer.
Di Lauro L; Barba M; Pizzuti L; Vici P; Sergi D; Di Benedetto A; Mottolese M; Speirs V; Santini D; De Maria R; Maugeri-Saccà M
Cancer Lett; 2015 Nov; 368(1):20-25. PubMed ID: 26276719
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumor subtypes in male breast cancer: a population-based study.
Leone JP; Leone J; Zwenger AO; Iturbe J; Vallejo CT; Leone BA
Breast Cancer Res Treat; 2015 Aug; 152(3):601-9. PubMed ID: 26126972
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progesterone receptors in breast cancer.
Yip CH; Rhodes A
Future Oncol; 2014 Nov; 10(14):2293-301. PubMed ID: 25471040
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer statistics, 2013.
DeSantis C; Ma J; Bryan L; Jemal A
CA Cancer J Clin; 2014; 64(1):52-62. PubMed ID: 24114568
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta in breast cancer.
Haldosén LA; Zhao C; Dahlman-Wright K
Mol Cell Endocrinol; 2014 Jan; 382(1):665-672. PubMed ID: 23954741
[TBL] [Abstract][Full Text] [Related]
12. Male breast cancer according to tumor subtype and race: a population-based study.
Chavez-Macgregor M; Clarke CA; Lichtensztajn D; Hortobagyi GN; Giordano SH
Cancer; 2013 May; 119(9):1611-7. PubMed ID: 23341341
[TBL] [Abstract][Full Text] [Related]
13. Cancer statistics, 2013.
Siegel R; Naishadham D; Jemal A
CA Cancer J Clin; 2013 Jan; 63(1):11-30. PubMed ID: 23335087
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.
Johansson I; Nilsson C; Berglund P; Lauss M; Ringnér M; Olsson H; Luts L; Sim E; Thorstensson S; Fjällskog ML; Hedenfalk I
Breast Cancer Res; 2012 Feb; 14(1):R31. PubMed ID: 22333393
[TBL] [Abstract][Full Text] [Related]
15. Male breast cancer: a review.
Fentiman I
Ecancermedicalscience; 2009; 3():140. PubMed ID: 22276005
[TBL] [Abstract][Full Text] [Related]
16. Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects.
Pemmaraju N; Munsell MF; Hortobagyi GN; Giordano SH
Ann Oncol; 2012 Jun; 23(6):1471-4. PubMed ID: 22085764
[TBL] [Abstract][Full Text] [Related]
17. Outcome of non-metastatic male breast cancer: 118 patients.
Arslan UY; Oksüzoğlu B; Ozdemir N; Aksoy S; Alkış N; Gök A; Kaplan MA; Gümüş M; Berk V; Uncu D; Baykara M; Colak D; Uyetürk U; Türker I; Işıkdoğan A
Med Oncol; 2012 Jun; 29(2):554-60. PubMed ID: 21573973
[TBL] [Abstract][Full Text] [Related]
18. Endocrine therapy for male breast cancer: rates of toxicity and adherence.
Visram H; Kanji F; Dent SF
Curr Oncol; 2010 Oct; 17(5):17-21. PubMed ID: 20975874
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
